Released Nov 2, 2023, after the close
10-Q filed Nov 2, 2023, 33 days after period end · 0001437749-23-030016
Q3 2023 · 10-Q
Revenue$288.49M$288.49M +6.5% vs Q3 2022+2.1% vs Q2 2023
Net Income$10.39M$10.39M N/M vs Q3 2022−36.2% vs Q2 2023
EPS Diluted$0.68$0.68 N/M vs Q3 2022−35.8% vs Q2 2023
Operating Income$13,025,000+219.4%
Operating Cash Flowderived$32,305,000N/M
Free Cash Flowderived$25,794,000N/M
Margins · derived
Operating margin4.5%+3.0 pt vs Q3 2022
Net margin3.6%+4.5 pt vs Q3 2022
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $288.49M | $270.84M | $276.74M | $250.63M |
| Net Income | $10.39M | -$2.43M | -$3.35M | $12.85M |
| EPS Diluted | $0.68 | -$0.16 | -$0.22 | $0.84 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Healthcare Corp · CIK 1047335 · Engraved from SEC EDGAR